Medreich Limited — Bromhexine Exporter Profile
Indian Pharmaceutical Exporter · #9 for Bromhexine · $337.7K export value · DGFT Verified
Medreich Limited is the #9 Indian exporter of Bromhexine with $337.7K in export value and 88 verified shipments. Medreich Limited holds a 2.1% market share in Bromhexine exports across 2 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
Medreich Limited — Bromhexine Export Profile: Buyers & Destinations
Where Does Medreich Limited Export Bromhexine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $303.2K | 86 | 89.8% |
| YEMEN, DEMOCRATIC | $17.5K | 1 | 5.2% |
| YEMEN | $17.1K | 1 | 5.1% |
Medreich Limited exports Bromhexine to 3 countries. The largest destination is AUSTRALIA accounting for 89.8% of Medreich Limited's Bromhexine shipments, followed by YEMEN, DEMOCRATIC (5.2%) and YEMEN (5.1%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bromhexine from Medreich Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MEDREICH AUSTRALIA PTY LTD | AUSTRALIA | $215.3K | 62 |
| MEDREICH AUSTRALIA PTY LIMITED | AUSTRALIA | $87.8K | 24 |
| AL-JABER PHARMA FOR DRUGS&MEDICAL | YEMEN, DEMOCRATIC | $17.5K | 1 |
| AL-JABAR PHARMA FOR DRUGS & MEDICAL | YEMEN | $17.1K | 1 |
Medreich Limited supplies Bromhexine to 4 buyers globally. The largest buyer is MEDREICH AUSTRALIA PTY LTD (AUSTRALIA), followed by MEDREICH AUSTRALIA PTY LIMITED (AUSTRALIA) and AL-JABER PHARMA FOR DRUGS&MEDICAL (YEMEN, DEMOCRATIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bromhexine Export Value and How Much Does Medreich Limited Contribute?
India exported $10.3M worth of Bromhexine through 1,945 shipments from 288 suppliers to 109 countries, serving 530 buyers globally. Medreich Limited contributes $337.7K to this total, accounting for 2.1% of India's Bromhexine exports. Medreich Limited ships Bromhexine to 3 countries through 4 buyers.
What Is the Average Shipment Value for Medreich Limited's Bromhexine Exports?
Medreich Limited's average Bromhexine shipment value is $3.8K per consignment, based on 88 shipments totaling $337.7K. The largest destination is AUSTRALIA (89.8% of Medreich Limited's Bromhexine exports).
How Does Medreich Limited Compare to Other Indian Bromhexine Exporters?
Medreich Limited ranks #9 among 288 Indian Bromhexine exporters with a 2.1% market share. The top 3 exporters are UMAVIDA PHARMA PRIVATE LIMITED ($2.6M), EMCURE PHARMACEUTICALS LIMITED ($2.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($907.7K). Medreich Limited processed 88 shipments to 2 destination countries.
What Bromhexine Formulations Does Medreich Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| BROMHEXINE HYDROCHLORIDE 8MG TABLETS (CH | $30.9K | 5 |
| BROMHEXINE HYDROCHLORIDE 8MG TABLETS CH | $28.1K | 4 |
| BROMHEXINE HYDROCHLORIDE 8MG TABLETS (PH | $26.3K | 15 |
| TERBUTALINE SULPHATE,BROMHEXINE HYDROCHL | $17.5K | 1 |
| TERBUTALINE SULPHATE,BROMHEXINE HYDROCHLORIDE AND GUAPHENESIN (MUCODIL)100ML(28704 PACKS) | $17.1K | 1 |
| BROMHEXINE HYDROCHLORIDE 8MG TABLETS PHARMACY ACTION CHESTY FORTE TABLETS 10X10S 9120 PACKS | $12.9K | 2 |
| BROMHEXINE HYDROCHLORIDE 8MG TABLETS PH | $12.3K | 7 |
| APO HEALTH CHESTY MUCUS RELIEF FORTE 8MG(BROMHEXINE HYDROCHLORIDE 8MG TABLETS)10X10S (14400 PACKS) | $10.4K | 1 |
| BROMHEXINE HYDROCHLORIDE 8MG TABLETS (CHEMISTS OWN CHESTY FORTE BROMHEXINE HYDROCHLORIDE 8MG TABLETS)10X10S(14394 PACKS) | $10.3K | 1 |
| BROMHEXINE HYDROCHLORIDE 8MG TABLETS (CHEMISTS OWN CHESTY FORTE BROMHEXINE HYDROCHLORIDE 8MG TABS) 10X10S (14472 PACKS) | $10.2K | 1 |
Medreich Limited exports 57 distinct Bromhexine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BROMHEXINE HYDROCHLORIDE 8MG TABLETS (CH with 5 shipments worth $30.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Bromhexine to Key Markets
What Medreich Limited must comply with to export Bromhexine to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medreich Limited Compare to Nearest Bromhexine Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | GLENMARK PHARMACEUTICALS LIMITED | $595.1K | 31 | 7 | $19.2K |
| 8 | SANPRAS HEALTHCARE PRIVATE LIMITED | $359.7K | 36 | 2 | $10.0K |
| 9 | MEDREICH LIMITED ★ | $337.7K | 88 | 2 | $3.8K |
| 10 | IPCA LABORATORIES LIMITED | $308.0K | 20 | 3 | $15.4K |
| 3 | MAXFORD HEALTHCARE | $300.0K | 6 | 1 | $50.0K |
Medreich Limited ranks #9 among 288 Indian Bromhexine exporters. Average shipment value of $3.8K compared to the market average of $35.7K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and SANPRAS HEALTHCARE PRIVATE LIMITED.
Which Indian Ports Ship Bromhexine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 303 | 15.6% |
| JNPT | 169 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 164 | 8.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 157 | 8.1% |
| AHEMDABAD ICD | 74 | 3.8% |
| SAHAR AIR | 73 | 3.8% |
| AHEMDABAD AIR ACC (INAMD4) | 72 | 3.7% |
| AHEMDABAD ICD (INSBI6) | 59 | 3.0% |
Geopolitical & Trade Policy Impact on Medreich Limited's Bromhexine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Medreich Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
About Medreich Limited
Medreich Limited exports 42 products worth $224.8M. Beyond Bromhexine, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bromhexine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bromhexine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 88 individual customs records matching Medreich Limited exporting Bromhexine, covering 57 formulations to 3 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 530+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bromhexine Export Data from Medreich Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Bromhexine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Bromhexine Stats
Company Overview
Top Products by Medreich Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bromhexine. For current shipment-level data, contact TransData Nexus.